Authors:
ENDERS G
DOTSCH J
BAUER J
NUTZENADEL W
HENGEL H
HAFFNER D
SCHALASTA G
SEARLE K
BROWN KE
Citation: G. Enders et al., LIFE-THREATENING PARVOVIRUS B19-ASSOCIATED MYOCARDITIS AND CARDIAC TRANSPLANTATION AS POSSIBLE THERAPY - 2 CASE-REPORTS, Clinical infectious diseases, 26(2), 1998, pp. 355-358
Authors:
SEARLE K
GUILLIARD C
WALLAT S
SCHALASTA G
ENDERS G
Citation: K. Searle et al., ACUTE PARVOVIRUS B19 INFECTION IN PREGNANT-WOMEN - AN ANALYSIS OF SERIAL SAMPLES BY SEROLOGICAL AND SEMIQUANTITATIVE PCR TECHNIQUES, Infection, 26(3), 1998, pp. 139-143
Citation: K. Searle et al., DEVELOPMENT OF ANTIBODIES TO THE NONSTRUCTURAL PROTEIN NS1 OF PARVOVIRUS B19 DURING ACUTE SYMPTOMATIC AND SUBCLINICAL INFECTION IN PREGNANCY - IMPLICATIONS FOR PATHOGENESIS DOUBTFUL, Journal of medical virology, 56(3), 1998, pp. 192-198
Citation: K. Searle et al., PARVOVIRUS B19 DIAGNOSIS IN PREGNANT-WOMEN - QUANTIFICATION OF IGG ANTIBODY-LEVELS (IU ML) WITH REFERENCE TO THE INTERNATIONAL PARVOVIRUS B19 STANDARD SERUM/, Infection, 25(1), 1997, pp. 32-34
Citation: K. Komischke et al., MATERNAL SERUM ALPHA-FETOPROTEIN AND HUMAN CHORIONIC-GONADOTROPIN IN PREGNANT-WOMEN WITH ACUTE PARVOVIRUS B19 INFECTION WITH AND WITHOUT FETAL COMPLICATIONS, Prenatal diagnosis, 17(11), 1997, pp. 1039-1046